Tests noninvasive checks to spot liver transplant complications early
Part of Digestive system clinical trials.
This study looks at how well noninvasive tests (tests that don’t require surgery or taking tissue) can detect complications after a liver transplant. It may help patients and teams find problems earlier using safer, easier monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a candidate for a liver transplant under standard (accepted) medical guidelines
- You can agree to take part and understand the study
- You can give informed consent (or consent can be obtained properly)
- You are not coming for a repeat liver transplant (not a re-transplant patient)
- Your transplant is not for fulminant hepatitis (a sudden, rapidly worsening liver failure)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to check donated livers that other transplant centers have turned down. The goal is to see if these livers can be safely used for people on the waiting list, potentially increasing the number of available organs.
This study looks at how special lab tests from tiny tissue samples (microarrays) could help guide diagnosis and treatment in people who receive a liver transplant. It may help doctors better understand what’s going on and choose care more accurately.
This trial tests a new way to preserve donated livers before transplant, which may help people with severe liver disease get a transplant sooner. It may be an option for patients with certain cancers or urgent liver failure.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
This study looks at blood markers of the immune system to see if they can predict complications after a liver transplant. It aims to help doctors personalize care and catch problems early.
Hear when a new Transplant; Failure, Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.